Home
Safety Considerations for the Development of Antibody Drug Conjugates
BioIVT: Trusted Biospecimen Provider
Nov 1, 2023
1,038 views
Carboxylesterases in Drug Metabolism: Challenges and Opportunities
Antibody-Drug Conjugates (ADCs): Current Research and Overcoming Challenges - Webinar Playback
Antibody Drug Conjugates: The end of chemotherapy | 2023 West Oncology Conference
ADC and Highly Potent Substance Containment - A Full Life Cycle Safety Innovation
Qualitative and Quantitative Bio-analysis of Antibody Drug Conjugates (ADCs) using Mass Spectrometry
Understanding How a Transporter Allows an Acetylated Amino Acid to Act as a Drug
Antibody Drug Conjugates for Cancer
Highlights from the Final ICH M12 Drug Interaction Studies Guideline
Next Generation Sequencing 1: Overview - Eric Chow (UCSF)
Antibody–Drug Conjugates for Solid Tumors: Progress, Possibilities, and Implications for Care
2023 August - Proteomics Informed PBPK Modeling to Predict Systemic and Tissue Drug Concentrations
Understanding BioIVT’s New Tiered Study Options: What Does it Mean for You?
Role of DMPK in Drug Discovery and Development
Amplifying the ADC Advantage: ADCs as the Next Frontier in Precision Lung Cancer Care
Part 11 - Evolution of Antibody Drug conjugates in cancer - Dr. Gail Phillips, USA
Voyage weather routing in practice with Hafnia and Coach Solutions - Digital Ship webinar on Oct 8
Manufacturing concepts for antibody-drug conjugates | Webinar
3M Green Works
Data Modeling for Power BI [Full Course] 📊
Stanford Med LIVE: The State of AI in Healthcare and Medicine